MSH6, an MMR protein, is less studied in LS, and the exact mechanism of inconsistent MSI and MMR results among endometrial cancer (EC) patients who are carriers of MSH6 mutations remains unclear. This evidence concerns the gene MSH6 and Leigh syndrome.